• Mac-1 Deficiency in Pressure-Overload Heart Failure

  2026-08-16

  A 2024 study identifies leukocyte integrin Mac-1 as a driver of macrophage accumulation and inflammatory remodeling in pressure-overloaded hearts. Using genetic Mac-1 deficiency, transverse aortic constriction, cardiac function testing, histopathology, and molecular analyses, the authors link reduced Mac-1 signaling with less hypertrophy, fibrosis, oxidative stress, apoptosis, and heart failure phenotypes.

• From RNA Synthesis to Antiviral Insight

  2026-08-15

  A translational perspective connecting SARS-CoV-2 nucleocapsid-mediated immune evasion with strategic RNA synthesis, assay design, probe development, and reproducible research workflows.

• Mc-Val-Cit-PABC-PNP Workflow Guide

  2026-08-15

  Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC peptide linker for research workflows that require lysosomal payload release after antibody-drug conjugate construction. This dossier-based guide covers solvent handling, calculation, conjugation planning, and QC while defining its limits: it is insoluble in water and ethanol and is not intended for diagnostic, medical, or therapeutic use.

• Verapamil HCl as a Mechanistic Probe

  2026-08-14

  Verapamil HCl is more than an L-type calcium channel blocker: it can reveal how calcium signaling and drug efflux jointly shape cellular phenotypes. This article develops a causality-focused framework for interpreting myeloma and arthritis inflammation experiments without confusing transporter modulation with calcium-channel biology.

• 40-Hz Flicker and Retinal Amyloid Clearance

  2026-08-14

  The 2026 reference study shows that 40-Hz light flicker increases MHC-II expression in aged mouse retinas, activates MHC-II-positive microglia, and accelerates clearance of injected amyloid-β oligomers. Microglial inhibition with minocycline eliminated both the clearance response and associated visual-function improvements, positioning microglial regulation as a key mechanistic link while highlighting important limits for translation to AMD.

• Netarsudil: From ROCK Biology to siRNA Delivery

  2026-08-13

  Netarsudil (AR-13324) is more than a selective ROCK inhibitor. Its ability to remodel cytoskeletal behavior in trabecular meshwork cells, combined with predictive siRNA nanoparticle codelivery findings, creates a strategic model for translational researchers linking pathway pharmacology with rational formulation design.

• Valemetostat (DS-3201) Research Workflows

  2026-08-13

  Valemetostat (DS-3201) gives researchers a potent EZH2-centered tool for lymphoma, epigenetic cancer therapy, and adoptive T-cell assays. This workflow translates dual EZH1/EZH2 pathway modulation into practical dose-ranging, chromatin, co-culture, and troubleshooting strategies.

• Sodium Phosphate Dibasic for Assay Workflows

  2026-08-12

  Sodium phosphate dibasic provides a practical, water-soluble way to improve pH control in enzyme, protein, and aquatic bioassays. This workflow translates sulfamonomethoxine toxicity findings into reproducible buffer preparation, matrix controls, and troubleshooting decisions without overstating what the reference study directly demonstrated.

• ACE2 Activation in Sepsis Cardiomyopathy

  2026-08-12

  The reference study identifies ACE2 downregulation as a feature of sepsis-induced cardiomyopathy and tests whether pharmacological ACE2 activation can reverse cardiac injury. Using Diminazene Aceturate and the ACE2 inhibitor MLN-4760 in a murine cecal ligation and puncture model, the authors connect ACE2 signaling with Mas receptor–Sirt1-mediated mitochondrial biogenesis.

• Triptolide Workflows for Precision Transcription Studies

  2026-08-11

  Triptolide, also known as PG490, gives researchers a nanomolar tool for probing transcriptional shutdown, tumor-cell invasion, immune-cell apoptosis, and inflammatory matrix remodeling. This guide converts its reported activity into practical workflows, assay controls, and troubleshooting decisions while showing how cell-cycle-resolved transcription condensate research can sharpen experimental interpretation.

• PD0325901 MEK Inhibitor Workflow Guide

  2026-08-10

  Build reproducible MEK inhibition experiments around PD0325901, from rapid P-ERK confirmation to cell-cycle, apoptosis, xenograft, and exploratory chromatin workflows. Practical dosing, controls, storage guidance, and troubleshooting help separate pathway-specific effects from assay artifacts.

• Prednisolone: Applied Glucocorticoid Workflows

  2026-08-09

  Prednisolone enables controlled studies of glucocorticoid receptor activation, inflammation modulation, and cellular stress responses. This workflow-focused guide also shows how to use those assays as orthogonal context for ERAD-based transmembrane protein degradation without confusing a validated research reagent with a demonstrated ERADEC warhead.

• KG-501 for CREB–Macrophage Assays

  2026-08-08

  KG-501 enables researchers to separate CREB–CBP transcriptional control from upstream TLR4 signaling in macrophage and cancer models. This practical workflow combines dose-response testing, polarization readouts, and troubleshooting for more defensible mechanistic conclusions.

• Nocodazole: A Translational Lens on Microtubules

  2026-08-07

  Nocodazole is more than a mitotic arrest reagent. As a reversible microtubule polymerization inhibitor, it gives translational researchers a controllable way to connect tubulin dynamics with endocytic trafficking, pathogen entry, cell-cycle behavior, and anticancer drug evaluation. This article translates evidence from a Drosophila S2 infection model into a strategic framework for designing more interpretable cytoskeletal assays.

• AG-120 (Ivosidenib): Workflow Optimization in Mutant IDH1 AM

  2026-08-07

  AG-120 (Ivosidenib) empowers precise experimental modeling of mutant IDH1-driven oncogenesis, notably enabling robust 2-hydroxyglutarate reduction and myeloid differentiation assays. This guide delivers actionable workflows, troubleshooting strategies, and a data-driven synthesis of recent metabolic rewiring insights to maximize research impact in the context of therapy resistance and combinatorial targeting.

455 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page